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Conclusion: This study has shown that accounting for the 
effects of the magnetic field during treatment planning 
allows for design of clinically acceptable lung SBRT 
treatments with a MR-linac. Furthermore, it was found that 
the ability of real-time tumor tracking to decrease dose 
exposure to healthy tissue was not degraded by a magnetic 
field. 
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Purpose or Objective: Combining the capabilities of high 
resolution soft tissue MR imaging and intensity modulated 
radiation therapy into a hybrid device has the potential to 
increase the accuracy of radiotherapy. However, it is known 
that the magnetic field of the MR manipulates the trajectory 
of the secondary electrons and leads to a deviation of dose 
especially at the interfaces between high and low density 
materials. This study aims to introduce a routine for the 
evaluation of magnetic field effects to dose delivery and plan 
optimization using Monte Carlo simulations. 
 
Material and Methods: An EGSnrc Monte Carlo environment, 
based on the egs++ class library, was developed which can be 
used for the simulation of IMRT treatment plans in the 
presence of a magnetic field, based on patient CT data. A 
routine for the processing of treatment planning parameters 
and Monte Carlo simulation data was implemented into the 
in-house open source treatment planning system matRad. In 
order to basically validate the implementation, dose 
distributions at 0 T were compared against collapsed cone 
calculations by the treatment planning system RayStation. 
The effect of a magnetic field to the dose distribution was 
investigated for simulations in a porcine lung phantom. Based 
on Monte Carlo simulations of patient specific beamlets, plan 
optimization was performed and analyzed.  
 
Results: Comparison showed that the Monte Carlo simulations 
of IMRT plans at 0 T are in good agreement with RayStation 
dose calculations. The effect of a 1.5 T lateral magnetic field 
on the dose distribution showed distinct alteration in tumor 
dose. Differences appear to be less when an opposing field 
technique is used. It could further be proven that the routine 
is capable of performing plan optimization based on Monte 
Carlo simulated beamlets in the presence of a magnetic field 
(see figure 1).  
 
Conclusion: A routine for dose calculation of IMRT plans with 
EGSnrc and for plan optimization based on Monte Carlo 
simulated beamlets using the in-house planning system 
matRad was developed. This implementation provides the 
possibility to analyze the effects of a magnetic field during 
radiotherapy in detail. Additionally it enables the 
investigation of optimization strategies for an MRI-LINAC 
system.  
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Purpose or Objective: High costs and limited capacity in 
proton therapy requires prioritizing according to expected 
benefit. The aim of this work is to quantify the clinical 
advantage of robust intensity-modulated proton therapy 
(IMPT) in terms of sparing of organs at risk (OARs) for three 
target volumes in treatment of gynaecological cancers 
compared with state-of-the-art intensity-modulated photon 
therapy (IMRT), and to evaluate for which target volume the 
benefit would justify the use of IMPT. 
 
Material and Methods: Three target volumes were included: 
pelvic region (primary or postoperative treatment; N=10, 6 
with boost dose), pelvic and para-aortic region (N=6, all with 
